logo
Select company
Select metric
$ -126.18MNet Cash Flow - Operations
VS
Market
5
Sector
12
Industry
19
History
-
$ 2.2Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -126.18M
3/31/2025$ -119.14M
12/31/2024$ -110.82M
9/30/2024$ -107.18M
6/30/2024$ -71.24M
3/31/2024$ -67.04M
12/31/2023$ -61.36M
9/30/2023$ -53.6M
6/30/2023$ -78.62M
3/31/2023$ -69.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Operations stands at $ -3.02M.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average CF - Operations has been $ -73.04M.
  • The median CF - Operations for TSCAN THERAPEUTICS INC during this period was $ -66.77M
  • TSCAN THERAPEUTICS INC reached its highest CF - Operations over the past 5 years at $ -3.02M.
  • The lowest CF - Operations recorded by TSCAN THERAPEUTICS INC in the same timeframe $ -126.18M

TSCAN THERAPEUTICS INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
CRVO : CERVOMED INC $ -23.31MFATE : FATE THERAPEUTICS INC $ -115.61MOVID : OVID THERAPEUTICS INC $ -40.07MARMP : ARMATA PHARMACEUTICALS INC $ -31.58MCBUS : CIBUS INC $ -52.95MCUE : CUE BIOPHARMA INC $ -28.14MVERU : VERU INC $ -28.92MSRZN : SURROZEN INC $ -18.66MPSTV : PLUS THERAPEUTICS INC $ -16.86MKRRO : KORRO BIO INC $ -67.27M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

TCRX - Net Cash Flow - Operations, Last 5 years

$ -126.18M

Minimum

Jun 30, 2025

$ -3.02M

Maximum

Dec 31, 2020

$ -73.04M

Average

$ -66.77M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 58.3M with a standard deviation of $ 142.13M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 508.1M
average$ 58.3M
median$ 10.91M
std$ 142.13M